
|Articles|June 28, 2012
BRI incidence higher in MMC augmented trabeculectomy
Incidence of bleb-related infection (BRI) is higher in Mitomycin C (MMC) augmented trabeculectomy but is reduced to a lower level.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval
2
From skepticism to clarity and focus: A family’s PRESBYOND experience
3
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
4
Patent granted to Kiora Pharmaceuticals' KIO-100 formulations
5















































